Fundz

Eliem Therapeutics reported raising $120 Million in an initial SEC Form D filing, from an offering of $120 Million

PUBLIC · CLYMJul 02, 2024

Amount Raised

$120 Million

$120 Million sold, per SEC Form D (first sale Jun 27, 2024)

Round Type

Venture

Wellesley HillsBiotechnologyHealthcareHealth Careresearch

Quick answer

Climb Bio, Inc. raised $120 Million in a funding round, dated June 27, 2024. Climb Bio, Inc. is based in Wellesley Hills, Massachusetts, United States.

How much did Climb Bio, Inc. raise?
Climb Bio, Inc. raised $120 Million in a funding round on June 27, 2024.
What does Climb Bio, Inc. do?
Eliem Therapeutics is developing life-changing therapies for nervous system disorders.
Where is Climb Bio, Inc. based and how big is it?
Climb Bio, Inc. is based in Wellesley Hills, Massachusetts, United States. Fundz records about 17 employees.
Who are the decision-makers at Climb Bio, Inc?
Fundz holds 3 contacts at Climb Bio, Inc., including the SVP, People & Workforce Strategy. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and research around the same time

Companies in the same sectors as Climb Bio, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Lipella Pharmaceuticals raised $120K on July 31, 2024.
  • Otolith Labs raised $4.9M (Series A) on July 29, 2024.
  • CEL-SCI Corporation raised $11M (Debt Financing) on July 29, 2024.
  • Clarapath raised $36M (Series B) on July 24, 2024.
  • Pelthos Therapeutics raised $750K on July 24, 2024.
  • Alumis raised $40M on July 17, 2024.

Who to call at Climb Bio, Inc., and when

A new round usually means Climb Bio, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Climb Bio, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Climb Bio, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Climb Bio, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Climb Bio, Inc.

Location

Wellesley Hills, Massachusetts, United States

About

Eliem Therapeutics is developing life-changing therapies for nervous system disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Climb Bio, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsAshley J., SVP, People & Workforce Strategy hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Climb Bio, Inc.'s next move

See what Strategic adds

Climb Bio, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.